RhumbLine Advisers’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Buy
137,382
+3,455
+3% +$46.5K ﹤0.01% 1878
2025
Q4
$1.5M Sell
133,927
-53,324
-28% -$610K ﹤0.01% 2026
2025
Q3
$2.16M Buy
187,251
+49,714
+36% +$582K ﹤0.01% 1865
2025
Q2
$1.68M Sell
137,537
-219
-0.2% -$2.75K ﹤0.01% 1976
2025
Q1
$1.97M Sell
137,756
-6,087
-4% -$95K ﹤0.01% 1817
2024
Q4
$2.29M Sell
143,843
-2,016
-1% -$39.9K ﹤0.01% 1815
2024
Q3
$3.5M Sell
145,859
-2,846
-2% -$65K ﹤0.01% 1607
2024
Q2
$2.96M Sell
148,705
-3,905
-3% -$76.1K ﹤0.01% 1677
2024
Q1
$3.04M Sell
152,610
-3,338
-2% -$64.5K ﹤0.01% 1680
2023
Q4
$3.5M Buy
155,948
+367
+0.2% +$7.58K ﹤0.01% 1620
2023
Q3
$3.15M Sell
155,581
-2,143
-1% -$48.6K ﹤0.01% 1609
2023
Q2
$4.03M Sell
157,724
-4,164
-3% -$110K ﹤0.01% 1506
2023
Q1
$4.82M Buy
161,888
+4,383
+3% +$127K 0.01% 1337
2022
Q4
$4.26M Buy
157,505
+8,273
+6% +$202K 0.01% 1375
2022
Q3
$3.25M Buy
149,232
+3,607
+2% +$94.2K ﹤0.01% 1488
2022
Q2
$3.98M Buy
145,625
+2,752
+2% +$79.1K 0.01% 1365
2022
Q1
$4.79M Buy
142,873
+162
+0.1% +$5.22K 0.01% 1342
2021
Q4
$4.95M Buy
142,711
+6,113
+4% +$198K 0.01% 1360
2021
Q3
$4.26M Sell
136,598
-17,279
-11% -$586K 0.01% 1447
2021
Q2
$5.6M Sell
153,877
-1,930
-1% -$79.8K 0.01% 1366
2021
Q1
$6.82M Sell
155,807
-5,558
-3% -$261K 0.01% 1228
2020
Q4
$7.4M Buy
161,365
+8,234
+5% +$343K 0.01% 1115
2020
Q3
$5.09M Sell
153,131
-15,143
-9% -$484K 0.01% 1156
2020
Q2
$4.95M Buy
168,274
+2,846
+2% +$82.4K 0.01% 1225
2020
Q1
$4.46M Buy
165,428
+7,175
+5% +$214K 0.01% 1090
2019
Q4
$5.33M Sell
158,253
-5,875
-4% -$213K 0.01% 1220
2019
Q3
$6.15M Buy
164,128
+5,304
+3% +$202K 0.01% 1076
2019
Q2
$6.93M Buy
158,824
+1,365
+0.9% +$58.4K 0.01% 1001
2019
Q1
$6.72M Buy
157,459
+2,749
+2% +$123K 0.01% 1001
2018
Q4
$6.93M Buy
154,710
+63,646
+70% +$3.33M 0.02% 903
2018
Q3
$6.24M Buy
91,064
+861
+1% +$55.4K 0.01% 963
2018
Q2
$5.16M Buy
90,203
+1,072
+1% +$56.6K 0.01% 1071
2018
Q1
$4.11M Sell
89,131
-5,087
-5% -$242K 0.01% 1164
2017
Q4
$4.35M Sell
94,218
-7,595
-7% -$349K 0.01% 1154
2017
Q3
$4.58M Buy
101,813
+1,376
+1% +$58.7K 0.01% 1092
2017
Q2
$3.94M Sell
100,437
-1,098
-1% -$41.5K 0.01% 1146
2017
Q1
$3.87M Buy
101,535
+3,562
+4% +$139K 0.01% 1169
2016
Q4
$3.62M Sell
97,973
-2,502
-2% -$89.4K 0.01% 1114
2016
Q3
$3.48M Buy
100,475
+4,094
+4% +$143K 0.01% 1084
2016
Q2
$3.13M Sell
96,381
-14,660
-13% -$449K 0.01% 1073
2016
Q1
$3.19M Buy
111,041
+7,600
+7% +$202K 0.01% 1088
2015
Q4
$3.46M Buy
103,441
+1,710
+2% +$53.2K 0.01% 1019
2015
Q3
$2.89M Buy
101,731
+5,725
+6% +$200K 0.01% 1123
2015
Q2
$3.89M Buy
96,006
+15,280
+19% +$686K 0.01% 991
2015
Q1
$3.97M Buy
80,726
+3,164
+4% +$147K 0.01% 962
2014
Q4
$3.53M Buy
+77,562
New +$3.05M 0.01% 994

Other funds holding AVNS